Search

everythinglearnresearchcommunity

for

Search:↓

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Hair loss common in men and women, limited treatments available.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

Finasteride has a higher risk of reproductive side effects than minoxidil.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Combination therapies work better than single treatments for hair loss.

Combined microneedling with minoxidil improves hair growth more than minoxidil alone but may cause mild side effects.

Antibody treatments show promise for hair loss but need more research.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

A new method found unlisted drugs in two popular hair serums, posing a health risk.

Recent advances in hair loss treatments show significant progress.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Ishige sinicola, a type of seaweed, may help hair grow by blocking a hair loss-related enzyme and boosting important cell growth.

Brazilian propolis was found to speed up hair growth in mice by increasing the growth of skin cells that form hair.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Only anti-androgenic drugs likely halt AGA progression.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Hair restoration surgery techniques can effectively treat scalp deformities and have evolved to provide natural-looking results.

Hair follicle regeneration possible, more research needed.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.